Principal Financial Group’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-11,993
Closed -$14.9K 2188
2025
Q3
$14.9K Buy
11,993
+1,611
+16% +$1.92K ﹤0.01% 2244
2025
Q2
$11.7K Buy
+10,382
New +$13.8K ﹤0.01% 2223
2024
Q3
Sell
-16,836
Closed -$39.2K 2230
2024
Q2
$39.2K Sell
16,836
-13,935
-45% -$41.1K ﹤0.01% 2301
2024
Q1
$138K Sell
30,771
-3,842
-11% -$16K ﹤0.01% 2235
2023
Q4
$111K Sell
34,613
-231,541
-87% -$657K ﹤0.01% 2260
2023
Q3
$844K Buy
266,154
+4,531
+2% +$19.9K ﹤0.01% 1862
2023
Q2
$1.3M Buy
261,623
+995
+0.4% +$5.38K ﹤0.01% 1810
2023
Q1
$1.29M Buy
260,628
+9,769
+4% +$62.7K ﹤0.01% 1821
2022
Q4
$1.58M Buy
250,859
+2,316
+0.9% +$21.4K ﹤0.01% 1802
2022
Q3
$2.68M Buy
248,543
+7,260
+3% +$98.7K ﹤0.01% 1668
2022
Q2
$2.75M Buy
241,283
+4,074
+2% +$36.2K ﹤0.01% 1734
2022
Q1
$2.16M Sell
237,209
-908
-0.4% -$9.46K ﹤0.01% 1851
2021
Q4
$3.55M Buy
238,117
+97,060
+69% +$1.71M ﹤0.01% 1763
2021
Q3
$3.63M Sell
141,057
-878
-0.6% -$20.8K ﹤0.01% 1773
2021
Q2
$3.7M Buy
141,935
+3,607
+3% +$103K ﹤0.01% 1786
2021
Q1
$4.88M Buy
138,328
+13,726
+11% +$463K ﹤0.01% 1674
2020
Q4
$3.15M Buy
124,602
+13,894
+13% +$453K ﹤0.01% 1695
2020
Q3
$4.17M Buy
110,708
+2,611
+2% +$98.4K ﹤0.01% 1525
2020
Q2
$4.63M Sell
108,097
-27,068
-20% -$979K ﹤0.01% 1460
2020
Q1
$2.63M Buy
135,165
+752
+0.6% +$17.9K ﹤0.01% 1516
2019
Q4
$3.49M Sell
134,413
-898
-0.7% -$24.7K ﹤0.01% 1623
2019
Q3
$3.69M Buy
135,311
+146
+0.1% +$4.16K ﹤0.01% 1599
2019
Q2
$3.63M Buy
135,165
+76,665
+131% +$2.14M ﹤0.01% 1618
2019
Q1
$1.69M Sell
58,500
-5,800
-9% -$168K ﹤0.01% 1759
2018
Q4
$1.73M Buy
+64,300
New +$1.71M ﹤0.01% 1739

Other funds holding ALLO